; (B) Federal activities undertaken to advance the inclusion of pregnant and lactating women in clinical research; and (C) additional recommendations for the Secretary regarding Federal activities to address gaps in knowledge and research regarding safe and effective therapies for pregnant and lactating women. (2) Public availability The Secretary shall make the reports required by paragraph (1) available on a public website of the Department of Health and Human Services. (g) Supplemental report on Department guidance (1) In general Not later than 2 years after the date of enactment of this Act, the Committee shall prepare and submit to the Secretary, the Committee on Health, Education, Labor, and Pensions of the Senate, and the Committee on Energy and Commerce of the House of Representatives a report to inform guidance of the Department of Health and Human Services to facilitate the conduct of clinical research involving pregnant and lactating women. (2) Contents The report under paragraph (1) shall include— (A) information on which clinical studies require consent from both biological parents, including information quantifying how requiring consent from both biological parents limits participation in such clinical studies; (B) best practices and recommendations for institutional review boards related to the inclusion of pregnant and lactating women in clinical research, including information on successes and challenges of using a centralized institutional review board